| Followers | 4048 |
| Posts | 152970 |
| Boards Moderated | 3 |
| Alias Born | 08/05/2009 |
Friday, September 03, 2021 2:23:35 PM
Recent IPHA News
- Number of Shares and Voting Rights of Innate Pharma as of February 19, 2026 • Business Wire • 02/19/2026 06:00:00 AM
- Nouveau nombre d’actions et de droits de vote d’Innate Pharma au 19 février 2026 • Business Wire • 02/19/2026 06:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/18/2026 11:17:44 AM
- Innate Pharma to Participate in the Leerink Partners Global Healthcare Conference • Business Wire • 02/18/2026 06:00:00 AM
- Innate Pharma participera à la conférence Leerink Partners Global Healthcare • Business Wire • 02/18/2026 06:00:00 AM
- Number of Shares and Voting Rights of Innate Pharma as of December 31, 2025 • Business Wire • 01/07/2026 06:00:00 AM
- Nouveau nombre d’actions et de droits de vote d’Innate Pharma au 31 décembre 2025 • Business Wire • 01/07/2026 06:00:00 AM
- Nouveau nombre d’actions et de droits de vote d’Innate Pharma au 18 décembre 2025 • Business Wire • 12/22/2025 06:00:00 AM
- Number of Shares and Voting Rights of Innate Pharma as of December 18, 2025 • Business Wire • 12/22/2025 06:00:00 AM
- Innate Pharma publie son calendrier financier pour 2026 • Business Wire • 12/11/2025 06:00:00 AM
- Innate Pharma Releases Its 2026 Financial Calendar • Business Wire • 12/11/2025 06:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/28/2025 02:07:51 PM
- Number of Shares and Voting Rights of Innate Pharma as of November 27, 2025 • Business Wire • 11/28/2025 06:00:00 AM
- Nouveau nombre d’actions et de droits de vote d’Innate Pharma au 27 novembre 2025 • Business Wire • 11/28/2025 06:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/17/2025 11:02:00 AM
- Innate Pharma to Present at Jefferies Global Healthcare Conference • Business Wire • 11/17/2025 06:00:00 AM
- Innate Pharma présentera lors de la Jefferies Global Healthcare Conference • Business Wire • 11/17/2025 06:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/13/2025 11:02:48 AM
- Innate Pharma Reports Third Quarter 2025 Business Update and Financial Results • Business Wire • 11/13/2025 06:00:00 AM
- Innate Pharma présente l'avancée de son portefeuille et ses résultats financiers du troisième trimestre 2025 • Business Wire • 11/13/2025 06:00:00 AM
- Innate Pharma reçoit l'autorisation de la FDA d'avancer TELLOMAK 3, un essai confirmatoire de Phase 3 évaluant lacutamab dans les lymphomes T cutanés • Business Wire • 11/10/2025 06:00:00 AM
- Innate Pharma Announces FDA Clearance to Proceed With TELLOMAK 3, a Confirmatory Phase 3 Trial of Lacutamab in CTCL • Business Wire • 11/10/2025 06:00:00 AM
- Innate Pharma Announces Conference Call and Webcast for Third Quarter 2025 Results and Business Updates • Business Wire • 11/05/2025 06:00:00 AM
- Innate Pharma organise une conférence téléphonique pour ses résultats financiers et l’avancée de son portefeuille au troisième trimestre 2025 • Business Wire • 11/05/2025 06:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 10/15/2025 10:15:11 AM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
DRCR Pushes Forward With Implementation of 2026 Business Plan • DRCR • Mar 11, 2026 12:26 PM
Record Gold Prices Reshape Opportunities for Emerging Producers • LFLR • Mar 11, 2026 9:00 AM
C2 Blockchain Reports 803 Million DOG (Bitcoin) Holdings Following Strategic Accumulation of Bitcoin-Native Digital Assets • CBLO • Mar 10, 2026 8:00 AM
RENI Completes Due Diligence on Target Acquisition; Confirms Strong Asset Base and Operational Performance • RENI • Mar 5, 2026 10:15 AM
BlackStar Engages in Talks with U.S. Senate Banking Committee Team Covering the Digital Asset Market Clarity Act • BEGI • Mar 4, 2026 4:47 PM

